aTYR Pharma INC
Biological Products, (No Diagnostic Substances) · San Diego, CA, United States
- PrincipalsJill Marie BroadfootChief Financial OfficerSanjay ShuklaPresident and CEOand 2 more
- CompanyaTYR Pharma INCSan Diego, CA, United States
- Phone line+1 (858) 731-8389General business
aTYR PHARMA INC is an SEC-registered Nasdaq-listed company (ticker ATYR) classified under SIC 2836: Biological Products, (No Diagnostic Substances).
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2836 — Biological Products, (No Diagnostic Substances) — SEC EDGAR company submissions
People 4
Chief executive
Sanjay ShuklaPresident and CEO
Chair & board
Paul SchimmelDirector (Board)
Finance
Jill Marie BroadfootChief Financial Officer
Legal
Nancy DenyesGeneral Counsel
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Jill Marie Broadfoot — Chief Financial Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Sanjay Shukla — President and CEO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Nancy Denyes — General Counsel
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Paul Schimmel — Director (Board)
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Adaptimmune Therapeutics PLCBiological Products, (No Diagnostic Substances) · Abingdon, Oxfordshire1 shared capabilityCrispr Therapeutics AGBiological Products, (No Diagnostic Substances) · Zug1 shared capabilityEntera Bio Ltd.Biological Products, (No Diagnostic Substances) · Jerusalem1 shared capabilityPluri Inc.Biological Products, (No Diagnostic Substances) · Haifa1 shared capabilityTeva Pharmaceutical Industries LtdPharmaceutical Preparations · Tel Aviv1 shared capabilityDBV Technologies S.A.Biological Products, (No Diagnostic Substances) · Chatillon1 shared capabilityAmarin Corp PLC\UKPharmaceutical Preparations · Dublin 21 shared capabilityAmneal Pharmaceuticals, Inc.Pharmaceutical Preparations1 shared capability